Načítá se...

P44. Activin A is novel circulating biomarker in lung cancer

BACKGROUND: Therapeutic decision making for the treatment of lung cancer is often a complex and challenging task. Biomarkers are urgently needed that can facilitate the early detection of these malignant diseases and can predict which therapeutic modality can significantly contribute to tumor contro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Lung Cancer Res
Hlavní autoři: Rozsas, Anita, Hoda, Mir Alireza, Klikovits, Thomas, Schlech, Karin, Laszlo, Viktoria, Grusch, Michael, Berger, Walter, Klepetko, Walter, Hegedus, Balazs, Dome, Balazs
Médium: Artigo
Jazyk:Inglês
Vydáno: Pioneer Bioscience Publishing Company 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367750/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB056
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!